Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

FSII

FS Development Corporati... (FSII)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FSII
DataOraFonteTitoloSimboloCompagnia
05/06/202322:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FSIIFS Development Corporation II
02/06/202322:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FSIIFS Development Corporation II
05/05/202322:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FSIIFS Development Corporation II
21/04/202322:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FSIIFS Development Corporation II
20/04/202313:54Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FSIIFS Development Corporation II
20/04/202313:50Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FSIIFS Development Corporation II
14/03/202321:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FSIIFS Development Corporation II
14/02/202323:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FSIIFS Development Corporation II
23/01/202322:23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FSIIFS Development Corporation II
23/01/202312:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FSIIFS Development Corporation II
18/01/202322:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:FSIIFS Development Corporation II
16/09/202222:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FSIIFS Development Corporation II
26/04/202212:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FSIIFS Development Corporation II
07/02/202222:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:FSIIFS Development Corporation II
28/01/202222:46Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:FSIIFS Development Corporation II
21/01/202222:29Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:FSIIFS Development Corporation II
30/12/202122:31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:FSIIFS Development Corporation II
27/12/202113:00GlobeNewswire Inc.Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19NASDAQ:FSIIFS Development Corporation II
23/12/202119:12Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:FSIIFS Development Corporation II
23/12/202117:16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FSIIFS Development Corporation II
21/12/202113:00Business WireFSII and Pardes Biosciences Move Towards Merger With the Goal of Tackling COVID-19 via an Oral Antiviral for Treatment and Prevention of SARS-CoV-2 InfectionsNASDAQ:FSIIFS Development Corporation II
01/12/202117:38Business WireFS Development Corp. II Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021NASDAQ:FSIIFS Development Corporation II
23/11/202122:53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:FSIIFS Development Corporation II
23/11/202122:38Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:FSIIFS Development Corporation II
26/08/202114:00GlobeNewswire Inc.Pardes Biosciences Initiates First-in-Human Trial for PBI-0451, an Oral Antiviral in Development to Treat and Prevent SARS-CoV-2 InfectionsNASDAQ:FSIIFS Development Corporation II
05/08/202113:00GlobeNewswire Inc.Pardes Biosciences Appoints Deborah M. Autor, J.D. and Laura J. Hamill to Board of DirectorsNASDAQ:FSIIFS Development Corporation II
29/06/202112:00Business WirePardes Biosciences & FS Development Corp. II Announce Merger Agreement Creating Publicly Listed Biopharmaceutical Company Adv...NASDAQ:FSIIFS Development Corporation II
17/02/202103:36Business WireFS Development Corp. II, Sponsored by Foresite Capital, Announces Pricing of Upsized $175 Million Initial Public OfferingNASDAQ:FSIIFS Development Corporation II
11/10/201222:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:FSIIFS Development Corporation II
11/10/201222:49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:FSIIFS Development Corporation II
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:FSII
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network